Health Bulletin 16/ February/ 2023
Here are top health stories for the day:Fake Pharma sponsored tours for doctors: UP Police arrest 'Medical Rep'A person posing as a medical representative of a leading pharmaceutical company was arrested by the cyber cell unit of Uttar Pradesh’s Special Task Force (UP-STF) from West Bengal after a doctor in Greater Noida complained that he was duped of ₹18.72 lakh by a...
Here are top health stories for the day:
Fake Pharma sponsored tours for doctors: UP Police arrest 'Medical Rep'
A person posing as a medical representative of a leading pharmaceutical company was arrested by the cyber cell unit of Uttar Pradesh’s Special Task Force (UP-STF) from West Bengal after a doctor in Greater Noida complained that he was duped of ₹18.72 lakh by a medical representative.
The Uttar Pradesh police on Tuesday said it has arrested a person who duped ''hundreds of doctors'' across several states to the tune of crores of rupees on the pretext of arranging foreign travel packages, officials said
For more details, check out the full story on the link below:
A Delhi court has set aside an order passed by the Metropolitan Magistrate directing the registration of FIR against a paediatric surgeon in a case accusing him of removing a two-year-old boy's kidney during nephrectomy in 2005, alleging criminal medical negligence.
For more details, check out the full story on the link below:
The NEET UG 2023 registrations are likely to begin at the end of February.
The registration was earlier scheduled between the second week of January and the last week of February.
While speaking with Indian Express, NTA Chief Vineet Joshi confirmed, "The registration for the National Eligibility cum Entrance Test Undergraduate (NEET UG) 2023 exam will commence by the end of this month."
For more details, check out the full story on the link below:
NEET 2023 Registrations Likely To Begin By February End: Report
CDSCO panel rejects Glenmark Pharma proposal for use of Nitric Oxide Nasal Spray for prevention of COVID 19
Citing lack of strong evidence on the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected the drug major Glenmark's proposal for the additional indication of Nitric Oxide Nasal Spray.
This came after the drug major Glenmark presented their proposal before the committee regarding the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection
For more details, check out the full story on the link below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd